微RNA在贝塞特病中的作用
Feihan Gu1, Xu Huang1, Wenkai Huang1
1College and Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, China.
Frontiers in immunology
|October 20, 2023
概括
贝切特病涉及多系统性炎症. 非编码RNAs,特别是microRNAs,是关键的调节器和潜在的生物标记物,但需要进一步研究治疗见解.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 贝切特病 (BD) 是一种多系统性炎症性疾病.
- 关键症状包括关节炎,,皮肤病变和器官系统的参与.
- 非编码RNAs (ncRNAs) 与自身免疫和炎症过程有关.
研究的目的:
- 探索ncRNAs,特别是microRNAs (miRNAs) 在贝赫塞特病中的作用.
- 突出miRNAs作为BD.诊断生物标记物的潜力.
- 强调需要进一步研究miRNA在BD中的生物功能.
主要方法:
- 文献综述侧重于贝塞特病中的ncRNAs.
- 对目前关于miRNA在BD病变发生中的作用的研究进行分析.
- 确定miRNAs的潜在诊断和治疗应用.
主要成果:
- ncRNAs,包括miRNAs,lncRNAs和circRNAs,在BD中至关重要.
- miRNAs特别有望作为贝赫塞病的诊断生物标志物.
- 现有的研究表明,miRNAs对于BD的生理和病理生理过程至关重要.
结论:
- ncRNAs是贝塞特病复杂机制中的重要参与者.
- miRNAs代表了BD诊断和潜在的治疗的有希望的途径.
- 进一步的研究至关重要,以充分阐明BD中的miRNAs的生物作用.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Fungal Phylum Microsporidia
21
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
21
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
148
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
148


